399 related articles for article (PubMed ID: 16813885)
1. Long-term followup of a randomized study of locally advanced prostate cancer treated with combined orchiectomy and external radiotherapy versus radiotherapy alone.
Granfors T; Modig H; Damber JE; Tomic R
J Urol; 2006 Aug; 176(2):544-7. PubMed ID: 16813885
[TBL] [Abstract][Full Text] [Related]
2. A randomized trial comparing radical prostatectomy plus endocrine therapy versus external beam radiotherapy plus endocrine therapy for locally advanced prostate cancer: results at median follow-up of 102 months.
Akakura K; Suzuki H; Ichikawa T; Fujimoto H; Maeda O; Usami M; Hirano D; Takimoto Y; Kamoto T; Ogawa O; Sumiyoshi Y; Shimazaki J; Kakizoe T;
Jpn J Clin Oncol; 2006 Dec; 36(12):789-93. PubMed ID: 17082219
[TBL] [Abstract][Full Text] [Related]
3. Androgen suppression plus radiation versus radiation alone for patients with stage D1/pathologic node-positive adenocarcinoma of the prostate: updated results based on national prospective randomized trial Radiation Therapy Oncology Group 85-31.
Lawton CA; Winter K; Grignon D; Pilepich MV
J Clin Oncol; 2005 Feb; 23(4):800-7. PubMed ID: 15681524
[TBL] [Abstract][Full Text] [Related]
4. Combined orchiectomy and external radiotherapy versus radiotherapy alone for nonmetastatic prostate cancer with or without pelvic lymph node involvement: a prospective randomized study.
Granfors T; Modig H; Damber JE; Tomic R
J Urol; 1998 Jun; 159(6):2030-4. PubMed ID: 9598512
[TBL] [Abstract][Full Text] [Related]
5. Immediate versus deferred hormonal treatment for patients with prostate cancer who are not suitable for curative local treatment: results of the randomized trial SAKK 08/88.
Studer UE; Hauri D; Hanselmann S; Chollet D; Leisinger HJ; Gasser T; Senn E; Trinkler FB; Tscholl RM; Thalmann GN; Dietrich D
J Clin Oncol; 2004 Oct; 22(20):4109-18. PubMed ID: 15483020
[TBL] [Abstract][Full Text] [Related]
6. Whole pelvic radiotherapy versus prostate only radiotherapy in the management of locally advanced or aggressive prostate adenocarcinoma.
Aizer AA; Yu JB; McKeon AM; Decker RH; Colberg JW; Peschel RE
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1344-9. PubMed ID: 19464821
[TBL] [Abstract][Full Text] [Related]
7. Excellent results from high dose rate brachytherapy and external beam for prostate cancer are not improved by androgen deprivation.
Demanes DJ; Brandt D; Schour L; Hill DR
Am J Clin Oncol; 2009 Aug; 32(4):342-7. PubMed ID: 19398902
[TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy.
Da Pozzo LF; Cozzarini C; Briganti A; Suardi N; Salonia A; Bertini R; Gallina A; Bianchi M; Fantini GV; Bolognesi A; Fazio F; Montorsi F; Rigatti P
Eur Urol; 2009 May; 55(5):1003-11. PubMed ID: 19211184
[TBL] [Abstract][Full Text] [Related]
9. Long-term results of patients with clinical stage C prostate cancer treated by phototherapy and early orchiectomy. A retrospective analysis of 169 cases.
Wiegel T; Tepel J; Schmidt R; Klosterhalfen H; Arps H; Berger P; Franke HD
Strahlenther Onkol; 1996 Nov; 172(11):596-603. PubMed ID: 8946031
[TBL] [Abstract][Full Text] [Related]
10. Influence of radiotherapy on node-positive prostate cancer treated with androgen ablation.
Sands ME; Pollack A; Zagars GK
Int J Radiat Oncol Biol Phys; 1995 Jan; 31(1):13-9. PubMed ID: 7527796
[TBL] [Abstract][Full Text] [Related]
11. Short- vs long-term androgen suppression plus external beam radiation therapy and survival in men of advanced age with node-negative high-risk adenocarcinoma of the prostate.
D'Amico AV; Denham JW; Bolla M; Collette L; Lamb DS; Tai KH; Steigler A; Chen MH
Cancer; 2007 May; 109(10):2004-10. PubMed ID: 17397033
[TBL] [Abstract][Full Text] [Related]
12. Timing and patterns of recurrences and deaths from prostate cancer following adjuvant pelvic radiotherapy for pathologic stage T3/4 adenocarcinoma of the prostate.
Anscher MS; Clough R; Robertson CN; Prosnitz LR; Dahm P; Walther P; Donatucci CF; Albala DM; Febbo P; George DJ; Sun L; Moul JW
Prostate Cancer Prostatic Dis; 2006; 9(3):254-60. PubMed ID: 16880828
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcome following three-dimensional conformal/intensity-modulated external-beam radiotherapy for clinical stage T3 prostate cancer.
Zelefsky MJ; Yamada Y; Kollmeier MA; Shippy AM; Nedelka MA
Eur Urol; 2008 Jun; 53(6):1172-9. PubMed ID: 18222596
[TBL] [Abstract][Full Text] [Related]
14. Laparoscopic pelvic lymph node dissection following definitive radiotherapy for carcinoma of the prostate.
Lund GO; Winfield HN; Donovan JF; See WA; Loening SA; Williams RD
J Urol; 1997 Feb; 157(2):548-51. PubMed ID: 8996353
[TBL] [Abstract][Full Text] [Related]
15. Luteinizing hormone-releasing hormone agonists in the treatment of prostate cancer: a review of their discovery, development, and place in therapy.
Moreau JP; Delavault P; Blumberg J
Clin Ther; 2006 Oct; 28(10):1485-508. PubMed ID: 17157109
[TBL] [Abstract][Full Text] [Related]
16. Intraoperative radiotherapy combined with adjuvant chemoradiotherapy for locally advanced gastric adenocarcinoma.
Fu S; Lu JJ; Zhang Q; Yang Z; Peng L; Xiong F
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1488-94. PubMed ID: 18538489
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era.
Boorjian SA; Thompson RH; Siddiqui S; Bagniewski S; Bergstralh EJ; Karnes RJ; Frank I; Blute ML
J Urol; 2007 Sep; 178(3 Pt 1):864-70; discussion 870-1. PubMed ID: 17631342
[TBL] [Abstract][Full Text] [Related]
18. Deferred treatment of locally advanced nonmetastatic prostate cancer: a long-term followup.
Adolfsson J; Steineck G; Hedlund PO
J Urol; 1999 Feb; 161(2):505-8. PubMed ID: 9915436
[TBL] [Abstract][Full Text] [Related]
19. [Cancer of the prostate: curative radiotherapy preceded by lymphadenectomy in 20 patients. Follow-up over 10 years].
Sarramon JP; Rischmann P; Albin N; Douchez J
Ann Urol (Paris); 1991; 25(4):188-91. PubMed ID: 1746926
[TBL] [Abstract][Full Text] [Related]
20. Combined androgen blockade in the management of advanced prostate cancer: a sensible or ostensible approach.
Ansari MS; Gupta NP; Hemal AK; Dogra PN; Seth A
Int J Urol; 2004 Dec; 11(12):1092-6. PubMed ID: 15663681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]